MWAIOTCFinance ServicesFiscal year ends June 30
MedWellAI, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.20−0.12 (-37.50%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2026
Gross margin
–
Operating margin
-234.2%+936.1 pts over 5 years
Net margin
-301.1%+910.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -11.2% | -48.5% | -22.2% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | 706.2% | -506.7% | 21.8% | |
| Return on assets | -1159.7% | -322.5% | -336.1% | |
| Current ratio | 0.85 | 40.38 | 0.01 | |
| Interest coverage | – | -49.7× | -23.6× | |
| Capex to revenue | – | 177.8% | 0.0% | |
| Diluted shares | 0M | 1M | – |
Where the cash went
Fiscal 2022 to 2026, five years combined
MedWellAI generated $8.77M from operations and spent $75.82K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$8.77M
Used
$75.82K
Capital expenditure$75.82K100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-301.1%
×Asset turnover1.12×
×Equity multiplier-0.06×
=Return on equity, FY202621.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | -301.1% | 1.12× | -0.06× | 21.8% |
| FY2025 | -606.5% | 0.25× | -0.45× | 68.8% |
| FY2023 | -659.1% | 0.34× | 2.27× | -505.0% |
| FY2022 | -8.6% | 0.44× | 1.52× | -5.8% |
| FY2021 | -1211.7% | 0.27× | 1.57× | -506.7% |
| FY2020 | -238.2% | 0.54× | -1.39× | 180.6% |
| FY2019 | -3408.0% | 0.29× | -0.60× | 590.3% |
| FY2018 | -1820.3% | 0.54× | -0.52× | 510.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
2of 6 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero-$1.59M
- Cash generatingOperating cash flow above zero-$307.03K
- Return on assets improvedROA up on the prior year-91.5% → -197.3%
- Earnings backed by cashOperating cash flow above net income-$307.03K vs -$1.59M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose0.14 → 0.01
- No dilutionShare count did not rise– → –
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.15 → 0.66